EDITION:

Search
Search
Close this search box.

Senate candidate hoping cannabis will bring voters to the polls

HIGH HOPES

PA Senate candidate is using cannabis legalization to draw voters to the polls

Pennsylvania Lt. Gov. John Fetterman, who is running for a Senate seat, is leaning into cannabis legalization as a way to lure voters to the polls, per Politico.

“It’s high time that we get our sh*t together and legalize weed in PA + USA,” reads his top-selling campaign T-shirt. “More justice, jobs, revenue, and freedom.”

“If [candidates] support marijuana, they’re more about the people,” said one 25-year-old voter. “I feel like even though they’re older, that they’re still listening to the younger people who are eventually going to be making America, America.”


Enjoy Cannabis Daily each morning at 7 a.m.

FDA FOR CBD

US Hemp Roundtable renews call for FDA regulation of CBD

A new study shows the relative safety of CBD, according to the US Hemp Roundtable, who renewed its calls on the Food and Drug Administration to regulate cannabidiol, per a press release.

The study involved 1,061 participants and 17 CBD companies and showed no evidence of:

  • “Elevated liver tests”
  • Lower testosterone levels in men
  • Daytime drowsiness

“The data in this study looks really good; it’s highly significant, and the chances of it being wrong are very, very small,” said Dr. Robert Kaufmann, director of research for Validcare and a former professor of medicine at Southern Illinois University School of Medicine. “I am very hopeful that this data will allow the FDA to regulate these popular CBD products.”


TOO LOW FOR HEXO

Tilray tried to buy Hexo in November at a premium, but its offer was rejected

In a document from BMO Capital Markets outlining possible ways Quebec-based Hexo could change its strategy, Tilray reportedly expressed interest in acquiring the company “at a price of “$2.00 to $3.00 per share” last November, according to TheDeepDive.ca.

“The Corporation concluded that this represented less than sufficient value and rejected Tilray’s offer, but agreed to enter into a confidentiality and standstill agreement on December 16, 2021,” reads the document.

At the time, Hexo was trading between $1.30 and $2.35.It’s currently trading at 41 cents, and according to the report, Tilray still intends to acquire 50% of the company after buying the rest of its debt. 


MO’ MONEY

Chill shareholders vote to raise £4 million 

Shareholders of international CBD company Chill Brands have voted to raise £4 million, which will be enough to keep the company going “this financial year,” according to CEO Somerton, per BusinessCann.

It will be an uphill battle for the 26-year-old head of the struggling company. Share prices are at an all-time low, and dropped 30% following the announcement.

“We are  also engaging in a cost cutting exercise, and our sales channels (especially digital) are expected to improve month on month,” Somerton said.. “All of these activities are intended to put Chill in a healthier financial position while creating a strong investment case.”

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?